GlassScriptPhysician profile
Steven Ferguson
NPI 1952309502
$5,756.60
in general payments reported to CMS, 2019-2025
18 companies · $664 in 2025
The $664 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,590 · 2020: $1,089 · 2021: $527 · 2022: $523 · 2023: $378 · 2024: $986 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,010 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,010.26 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $1,893.89 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $922.33 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $661.04 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Sight Sciences, INC. | $560.39 | 2019-2023 | Tearcare System |
| Dompe US, INC. | $435.45 | 2021-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $392.91 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $190.41 | 2021-2022 | |
| Abbvie INC. | $187.49 | 2022-2023 | |
| Sun Pharmaceutical Industries INC. | $79.05 | 2020-2025 | |
| Mallinckrodt Hospital Products INC. | $77.22 | 2024 | Acthar |
| Rxsight INC | $76.99 | 2025 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Alcon Vision LLC | $70.88 | 2024-2025 | Tryptyr, Argos, Systane |
| Allergan, INC. | $59.34 | 2020-2021 | |
| Biotissue Holdings INC. | $57.53 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $34.65 | 2020-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $24.31 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.39 | 2021 | |
| Coopervision INC. | $16.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.